维普期刊资源整合服务平台（V6.5）

69篇 您的检索式：作者名="Muller CM"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation 显示文摘	Keck CM Muller RH	2006	Eur J Pharm Biopharm2006，62，1：	1
2	Ductus venosus studiesin fetuses at high risk for chromosomal or heart abnormalities: rela-tionship with nuchal translucency measurement and fetal outcome显示文摘	Bilardo CM Muller MA Zikulnig L	2011	Ultrasound obstet Gynecol2011，17，4：	1
3	Challenges and solutions for the de- livery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles 显示文摘	MULLER RH KECK CM	2004	J Biotechnol2004，1，113：	1
4	Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation显示文摘	Keck CM Muller RH	2006	Eur J Pharm Biopharm2006，62，1：	1
5	State of nanocrystals-Special features, production, nano toxicology aspects and intracellular de livery显示文摘	Muller RH Sven Gohla Keck CM	2011	European Journal of Pharmaceutics and Biopharmaceu tics2011，78，：	1
6	Development of an oral rutin na-nocrystal formulation显示文摘	Mauludin R Muller RH Keck CM	2009	Int J Pharm2009，370，12：	1
7	Drug nanocrystals of poorly soluble drugsproduced by high pressure homogenisation 显示文摘	Keck CM Muller RH	2006	Eur J Pharm Bio-pharm2006，62，1：	1
8	RhoA-ROCK signaling is involved in contraction-mediated inhibition of SERCA2a expression in cardiomyocytes 显示文摘	Vlasblom R Muller A Beckers CM	2009	Pflugers Arch2009，458，4：	1
9	Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation 显示文摘	Keck CM Muller RH	2006	Eur J Pharm Biopharm2006，62，1：	1
10	Drug delivery to the brain-realization by novel drug carriers显示文摘	Muller RH Keck CM	2004	J Nanosci Nanotechnol2004，4，：	1
11	Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability显示文摘	Muller CM de Vos RA Maurage CA	2005	J Neuropathol Exp Neurol2005，64，7：	1
12	Challenges and solutions for the delivery of biotech drugs -a review of drug nanocrystal technology and lipid nanoparticles 显示文摘	Muller RH Keek CM	2004	J Biotechnol2004，113，13：	1
13	Challenges and solutions for the delivery of biotech drugs: a review of drug nanocrystal technology and lipid nanoparticles 显示文摘	Muller RH Keck CM	2004	J Biotechnol2004，113，13：	1
14	Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation显示文摘	Keck CM Muller RH	2006	Eur J Pharm Biopharm2006，62，1：	1
15	Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation 显示文摘	CM Keck RH Muller	2006	Eur J Pharm Biopharm2006，62，1：	1
16	When moderation i- mediated and mediation is moderated 显示文摘	Muller D Judd CM Yzerbyt Y V	2005	Journal of Personality and Social Psychology2005，89，6：	1
17	20 years of lipid nanoparticles(SLN and NLC):present state of development and industrial applications显示文摘	Muller RH Shegokar R Keck CM	2011	Curr Drug Discov Technol2011，8，3：	1
18	P-glycoprotein mediated multidrug resistance and its implications for pathology显示文摘	Trambas CM Muller HK Woods GM	1997	Pathology1997，29，2：	1
19	Seasonal changes in astrocytes parallel neuronal plasticity in the song control area HVc of the canary显示文摘	Guttinger HR Muller CM	1999	Glia1999，27，1：	1
20	Salt water bathing prior to UVB irradiation leads to a decrease of the minimal erythema dose and an increased erythema index without affecting skin pigmentation显示文摘	Schempp CM Muller K Schulte-Monting J	1999	Photochem Photobiol1999，69，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示